Nkure Therapeutics
Developer of anticancer immunotherapies intended to provide affordable natural killer cell-based therapies. The company offers therapies effective against leukemia, multiple myeloma, lymphoma, and sol...
Valuation
$0
Share Price
N/A
Total Raised
$2.4M
Last Round
N/A